G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial

被引：0
|
作者：
Link, H
Wandt, H
SchonrockNabulsi, P
Ehninger, G
Franke, A
Gackle, R
Geer, T
Gramatzki, M
Linkesch, W
Lutz, D
Niederwieser, D
Nikiforakis, E
Ohl, S
Otremba, B
Pittermann, E
Schmidt, H
Tischler, J
Weiss, J
Wilhelm, M
Deutschmann, S
机构：
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1996年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：841 / 841
页数：1
相关论文
共 50 条
  • [1] G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial
    Montillo, M
    Mirto, S
    Pinto, A
    Tedeschi, A
    Magrin, S
    Zagonel, V
    Leoni, P
    Caronia, F
    Cimino, R
    Ferrara, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 842 - 842
  • [2] G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled trial.
    Link, H
    Wandt, H
    SchonrockNabulsi, P
    Ehninger, G
    Franke, A
    Gackle, R
    Geer, T
    Strobel, G
    Linkesch, W
    Krieger, O
    Niederwieser, D
    Nikiforakis, E
    Ohl, S
    Otremba, B
    Pittermann, E
    Schmidt, H
    Tischler, J
    Weiss, J
    Wilhelm, M
    Badri, N
    [J]. BLOOD, 1996, 88 (10) : 2654 - 2654
  • [3] G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled randomized trial.
    Link, H
    Wandt, H
    SchonrockNabulsi, P
    Ehninger, G
    Franke, A
    Gackle, R
    Geer, T
    Strobel, G
    Linkesch, W
    Krieger, O
    Niederwieser, D
    Nikiforakis, E
    Ohl, S
    Otremba, B
    Pittermann, E
    Schmidt, H
    Tischler, J
    Weiss, J
    Wilhelm, M
    Badri, N
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 35 - 35
  • [4] G-CSF after intensive consolidation chemotherapy in acute myeloid leukemia (AML).
    Harousseau, JL
    Witz, F
    Desablens, B
    Leprise, PY
    Francois, S
    Delain, M
    Abgrall, JF
    Solary, E
    [J]. BLOOD, 1997, 90 (10) : 2249 - 2249
  • [5] G-CSF after intensive consolidation chemotherapy (ICC) in acute myeloid leukemia (AML)
    Harousseau, JL
    Witz, F
    Lioure, B
    Leprise, PY
    Solary, E
    Abgrall, JF
    Cassasus, P
    Audhuy, B
    Travade, P
    Cahn, JY
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 86 - 86
  • [6] Flow cytometric G-CSF receptor expression in acute myeloid leukemia and role in G-CSF use at induction chemotherapy
    Kutlay, S
    Beksaç, M
    Dalva, K
    Ilhan, O
    Koç, H
    Akan, H
    Özcan, M
    Konuk, N
    Uysal, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 87 - 87
  • [7] A single-center,randomized controlled trial of PEG-rh G-CSF and common rh G-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia
    刘凯奇
    [J]. China Medical Abstracts (Internal Medicine), 2019, 36 (03) : 185 - 186
  • [8] Intensive chemotherapy with idarubicin, cytarabine and G-CSF in elderly patients with acute myelogenous leukemia (AML)
    Chaibi, P
    Dombret, H
    Rousselot, P
    Gardin, C
    Glaisner, S
    Castaigne, S
    Degos, L
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 822 - 822
  • [9] G-CSF IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - IS IT SAFE
    OHNO, R
    [J]. LEUKEMIA & LYMPHOMA, 1993, 11 : 15 - 19
  • [10] A double blind placebo controlled trial of G-CSF in elderly patients with previously untreated acute myeloid leukemia. A southwest oncology group study.
    Godwin, JE
    Kopecky, KJ
    Head, DR
    Hynes, HE
    Balcerzak, SP
    Appelbaum, FR
    [J]. BLOOD, 1995, 86 (10) : 1723 - 1723
12345